BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20448000)

  • 1. Commentary-FSH and bone 2010: evolving evidence.
    Iqbal J; Sun L; Zaidi M
    Eur J Endocrinol; 2010 Jul; 163(1):173-6. PubMed ID: 20448000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FSH versus estrogen: who's guilty of breaking bones?
    Baron R
    Cell Metab; 2006 May; 3(5):302-5. PubMed ID: 16679287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence for direct pro-resorptive actions of FSH.
    Sun L; Zhang Z; Zhu LL; Peng Y; Liu X; Li J; Agrawal M; Robinson LJ; Iqbal J; Blair HC; Zaidi M
    Biochem Biophys Res Commun; 2010 Mar; 394(1):6-11. PubMed ID: 20171951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FSH, Bone Mass, Body Fat, and Biological Aging.
    Zaidi M; Lizneva D; Kim SM; Sun L; Iqbal J; New MI; Rosen CJ; Yuen T
    Endocrinology; 2018 Oct; 159(10):3503-3514. PubMed ID: 30085049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone metabolism by sex hormones and gonadotropins].
    Imai Y
    Clin Calcium; 2014 Jun; 24(6):815-9. PubMed ID: 24870831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition.
    Zaidi M; Blair HC; Iqbal J; Davies TF; Zhu LL; Zallone A; Sun L
    Curr Rheumatol Rep; 2009 Jul; 11(3):191-5. PubMed ID: 19604463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradigm shift in the pathophysiology of postmenopausal and thyrotoxic osteoporosis.
    Zaidi M; Iqbal J; Blair HC; Zallone A; Davies T; Sun L
    Mt Sinai J Med; 2009 Oct; 76(5):474-83. PubMed ID: 19787657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FSH and bone--important physiology or not?
    Prior JC
    Trends Mol Med; 2007 Jan; 13(1):1-3. PubMed ID: 17141571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FSH directly regulates bone mass.
    Sun L; Peng Y; Sharrow AC; Iqbal J; Zhang Z; Papachristou DJ; Zaidi S; Zhu LL; Yaroslavskiy BB; Zhou H; Zallone A; Sairam MR; Kumar TR; Bo W; Braun J; Cardoso-Landa L; Schaffler MB; Moonga BS; Blair HC; Zaidi M
    Cell; 2006 Apr; 125(2):247-60. PubMed ID: 16630814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging concepts in the epidemiology, pathophysiology, and clinical care of osteoporosis across the menopausal transition.
    Lizneva D; Yuen T; Sun L; Kim SM; Atabiekov I; Munshi LB; Epstein S; New M; Zaidi M
    Matrix Biol; 2018 Oct; 71-72():70-81. PubMed ID: 29738833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone loss in ovariectomized rats: dominant role for estrogen but apparently not for FSH.
    Rouach V; Katzburg S; Koch Y; Stern N; Somjen D
    J Cell Biochem; 2011 Jan; 112(1):128-37. PubMed ID: 21053364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormones and osteoporosis update. Possible roles of pituitary hormones, TSH and FSH, for bone metabolism].
    Takeuchi Y
    Clin Calcium; 2009 Jul; 19(7):977-83. PubMed ID: 19567994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FSH, bone, belly and brain.
    Kim SM; Sultana F; Sims S; Gimenez-Roig J; Laurencin V; Pallapati A; Rojekar S; Frolinger T; Zhou W; Gumerova A; Macdonald A; Ryu V; Lizneva D; Korkmaz F; Yuen T; Zaidi M
    J Endocrinol; 2024 Jul; 262(1):. PubMed ID: 38579764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal Transition.
    Zhu D; Li X; Macrae VE; Simoncini T; Fu X
    Trends Endocrinol Metab; 2018 Aug; 29(8):571-580. PubMed ID: 29983231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis.
    Colaianni G; Cuscito C; Colucci S
    Clin Dev Immunol; 2013; 2013():382698. PubMed ID: 23818914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FSH-metabolic circuitry and menopause.
    Taneja C; Gera S; Kim SM; Iqbal J; Yuen T; Zaidi M
    J Mol Endocrinol; 2019 Oct; 63(3):R73-R80. PubMed ID: 31454787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroids, not FSH, influence bone mass.
    Seibel MJ; Dunstan CR; Zhou H; Allan CM; Handelsman DJ
    Cell; 2006 Dec; 127(6):1079; author reply 1080-1. PubMed ID: 17174881
    [No Abstract]   [Full Text] [Related]  

  • 18. FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women.
    Rendina D; Gianfrancesco F; De Filippo G; Merlotti D; Esposito T; Mingione A; Nuti R; Strazzullo P; Mossetti G; Gennari L
    Eur J Endocrinol; 2010 Jul; 163(1):165-72. PubMed ID: 20335500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone.
    Gao J; Tiwari-Pandey R; Samadfam R; Yang Y; Miao D; Karaplis AC; Sairam MR; Goltzman D
    Endocrinology; 2007 Jun; 148(6):2613-21. PubMed ID: 17332067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.
    Zhu LL; Blair H; Cao J; Yuen T; Latif R; Guo L; Tourkova IL; Li J; Davies TF; Sun L; Bian Z; Rosen C; Zallone A; New MI; Zaidi M
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14574-9. PubMed ID: 22908268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.